Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
The Permanente Journal
|
May 25, 2013
Predictors of lung cancer: noteworthy cell type differences
H Nicole Tran, Yan Li, Stanton Siu, et al.
JCO Clinical Cancer Informatics
|
June 5, 2024
Population-Level Identification of Patients With Lynch Syndrome for Clinical Care, Quality Improvement, and Research
Ravi N Sharaf, Natalia Udaltsova, Dan Li, et al.
Pharmacoepidemiology and Drug Safety
|
December 7, 2011
Risk of cancer in patients exposed to gabapentin in two electronic medical record systems
Michael C Irizarry, David J Webb, Nada Boudiaf, et al.
The Permanente Journal
|
March 19, 2015
Alcohol intake, beverage choice, and cancer: a cohort study in a large kaiser permanente population
Arthur L Klatsky, Yan Li, H Nicole Tran, et al.
Circulation
|
March 4, 2009
Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study
Alan S Go, Margaret C Fang, Natalia Udaltsova, et al.
Digestive Diseases and Sciences
|
August 25, 2017
Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents
Hung-Viet Pham, Imran Hasan, Natalia Udaltsova, et al.
Stroke
|
April 28, 2012
Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants
Margaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American College of Cardiology
|
July 16, 2011
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
Margaret C Fang, Alan S Go, Yuchiao Chang, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 25, 2009
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study
Daniel E Singer, Yuchiao Chang, Margaret C Fang, et al.
Circulation. Cardiovascular Quality and Outcomes
|
October 21, 2010
Warfarin discontinuation after starting warfarin for atrial fibrillation
Margaret C Fang, Alan S Go, Yuchiao Chang, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
The Permanente Journal
|
May 25, 2013
Predictors of lung cancer: noteworthy cell type differences
H Nicole Tran, Yan Li, Stanton Siu, et al.
JCO Clinical Cancer Informatics
|
June 5, 2024
Population-Level Identification of Patients With Lynch Syndrome for Clinical Care, Quality Improvement, and Research
Ravi N Sharaf, Natalia Udaltsova, Dan Li, et al.
Pharmacoepidemiology and Drug Safety
|
December 7, 2011
Risk of cancer in patients exposed to gabapentin in two electronic medical record systems
Michael C Irizarry, David J Webb, Nada Boudiaf, et al.
The Permanente Journal
|
March 19, 2015
Alcohol intake, beverage choice, and cancer: a cohort study in a large kaiser permanente population
Arthur L Klatsky, Yan Li, H Nicole Tran, et al.
Circulation
|
March 4, 2009
Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study
Alan S Go, Margaret C Fang, Natalia Udaltsova, et al.
Digestive Diseases and Sciences
|
August 25, 2017
Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents
Hung-Viet Pham, Imran Hasan, Natalia Udaltsova, et al.
Stroke
|
April 28, 2012
Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants
Margaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American College of Cardiology
|
July 16, 2011
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
Margaret C Fang, Alan S Go, Yuchiao Chang, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 25, 2009
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study
Daniel E Singer, Yuchiao Chang, Margaret C Fang, et al.
Circulation. Cardiovascular Quality and Outcomes
|
October 21, 2010
Warfarin discontinuation after starting warfarin for atrial fibrillation
Margaret C Fang, Alan S Go, Yuchiao Chang, et al.
Page
of 7